Why you shouldn’t overlook Canadian IP litigation

While Canada is known for its natural resources and universal healthcare, it is often overlooked as a jurisdiction to litigate IP disputes.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Regulation & Industry

Fran Salisbury: ‘There’s nothing quite like finding the missing piece’

5 August 2026 From advising pioneering startups to championing women in the profession, Fran Salisbury of Mewburn Ellis has spent her career making innovation count. Here, she reflects on the challenges, opportunities and motivations that continue to drive her.

Careers

K&L Gates expands European practice with Munich team hire

5 August 2026 Strategic addition marks the latest investment in the firm’s European platform as demand for cross-border patent expertise continues to grow.

Careers

Patent litigator joins Baker Botts in London as UPC grows in significance

5 August 2026 With more than 25 years’ experience, the ex-EIP partner specialises in technology and life sciences, particularly SEPs and FRAND in the UK and Europe.

More features

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

Patent office fee increases: What applicants must know

IndiaMart v CDSCO: A test of intermediary liability

Part I: Ozempic goes generic as Novo’s key patent expires

Emotional Perception: What next for patent holders?

Rooted in rights: Lessons from plant patent infringement and invalidity cases

How AI will be shaped by legal and regulatory developments in 2026

Key EU and UK regulatory changes to watch for in 2026

Why you shouldn’t overlook Canadian IP litigation

More on this story

Editor's picks

Editor's picks

More features